Literature DB >> 8360113

Pyripyropenes, highly potent inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus.

S Omura, H Tomoda, Y K Kim, H Nishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8360113     DOI： 10.7164/antibiotics.46.1168

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  25 in total

1.  Biosynthesis: not just passing through.

Authors:  Jason M Crawford; Jon Clardy
Journal:  Nat Chem       Date:  2010-10       Impact factor: 24.427

2.  Reconstitution of a fungal meroterpenoid biosynthesis reveals the involvement of a novel family of terpene cyclases.

Authors:  Takayuki Itoh; Kinya Tokunaga; Yudai Matsuda; Isao Fujii; Ikuro Abe; Yutaka Ebizuka; Tetsuo Kushiro
Journal:  Nat Chem       Date:  2010-08-01       Impact factor: 24.427

3.  Insecticidal properties of pyripyropene A, a microbial secondary metabolite, against agricultural pests.

Authors:  Ryo Horikoshi; Kimihiko Goto; Masaaki Mitomi; Kazuhiko Oyama; Toshiaki Sunazuka; Satoshi Ōmura
Journal:  J Pestic Sci       Date:  2018-11-20       Impact factor: 1.519

4.  New natural products isolated from Metarhizium robertsii ARSEF 23 by chemical screening and identification of the gene cluster through engineered biosynthesis in Aspergillus nidulans A1145.

Authors:  Hiroki Kato; Yuta Tsunematsu; Tsuyoshi Yamamoto; Takuya Namiki; Shinji Kishimoto; Hiroshi Noguchi; Kenji Watanabe
Journal:  J Antibiot (Tokyo)       Date:  2016-05-18       Impact factor: 2.649

5.  New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.

Authors:  Taichi Ohshiro; Masaki Ohtawa; Tohru Nagamitsu; Daisuke Matsuda; Hiroaki Yagyu; Matthew A Davis; Lawrence L Rudel; Shun Ishibashi; Hiroshi Tomoda
Journal:  J Pharmacol Exp Ther       Date:  2015-09-03       Impact factor: 4.030

6.  In vitro metabolism of pyripyropene A and ACAT inhibitory activity of its metabolites.

Authors:  Daisuke Matsuda; Taichi Ohshiro; Masaki Ohtawa; Hiroyuki Yamazaki; Tohru Nagamitsu; Hiroshi Tomoda
Journal:  J Antibiot (Tokyo)       Date:  2014-07-09       Impact factor: 2.649

7.  Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.

Authors:  Ichiji Namatame; Hiroshi Tomoda; Shun Ishibashi; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

8.  Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages.

Authors:  Motohiro Sekiya; Daisuke Yamamuro; Taichi Ohshiro; Akira Honda; Manabu Takahashi; Masayoshi Kumagai; Kent Sakai; Shuichi Nagashima; Hiroshi Tomoda; Masaki Igarashi; Hiroaki Okazaki; Hiroaki Yagyu; Jun-ichi Osuga; Shun Ishibashi
Journal:  J Lipid Res       Date:  2014-06-02       Impact factor: 5.922

Review 9.  Terpene synthases in disguise: enzymology, structure, and opportunities of non-canonical terpene synthases.

Authors:  Jeffrey D Rudolf; Chin-Yuan Chang
Journal:  Nat Prod Rep       Date:  2020-03-25       Impact factor: 13.423

10.  Tricyclic pyrone compounds prevent aggregation and reverse cellular phenotypes caused by expression of mutant huntingtin protein in striatal neurons.

Authors:  Eugenia Trushina; Sandeep Rana; Cynthia T McMurray; Duy H Hua
Journal:  BMC Neurosci       Date:  2009-07-08       Impact factor: 3.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.